The House Oversight Committee released two major reports Wednesday that expose the internal strategies used by drug makers Celgene and Teva to repeatedly jack up the price of their blockbuster drugs revlimid and copaxone.

Starting Oct. 1, several private health insurers will no longer fully pay for virtual visits under certain circumstances — effectively reinstituting costs for patients reliant on the virtual care that has been heralded as a lifeline at a time when Covid-19 is still killing more than 700 Americans each day.

California could make its own insulin and other prescription drugs in an effort to lower costs under a bill Gov. Gavin Newsom announced he signed into law Monday.

U.S. employers, battered by rising hospital and pharmaceutical prices, are increasingly open to a bigger government role in healthcare, including regulating prices and expanding Medicare to more working Americans.

Beam, CaliforniaChoice, Kaiser Permanente and Oscar partner with Vericred to create a de facto standard for California group enrollment and member management

A nationwide cyberattack has crippled operations at Universal Health Services, one of the nation's largest health care providers.